502 related articles for article (PubMed ID: 15371822)
1. Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter.
Czito B; Zietman A; Kaufman D; Skowronski U; Shipley W
J Urol; 2004 Oct; 172(4 Pt 1):1271-5. PubMed ID: 15371822
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant radiotherapy in high stage transitional cell carcinoma of the renal pelvis and ureter.
Cozad SC; Smalley SR; Austenfeld M; Noble M; Jennings S; Reymond R
Int J Radiat Oncol Biol Phys; 1992; 24(4):743-5. PubMed ID: 1429099
[TBL] [Abstract][Full Text] [Related]
3. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?
Maulard-Durdux C; Dufour B; Hennequin C; Chrétien Y; Vignes B; Droz D; Delanian S; Housset M
J Urol; 1996 Jan; 155(1):115-7. PubMed ID: 7490805
[TBL] [Abstract][Full Text] [Related]
4. Patterns of failure and prognostic factors for locoregional recurrence after radical surgery in upper urinary tract transitional cell carcinoma: implications for adjuvant radiotherapy.
Jang NY; Kim IA; Byun SS; Lee SE; Kim JS
Urol Int; 2013; 90(2):202-6. PubMed ID: 23257513
[TBL] [Abstract][Full Text] [Related]
5. Impact of Tumor Location on Local Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma: Implications for Adjuvant Radiotherapy.
Yoo S; You D; Jeong IG; Hong B; Hong JH; Ahn H; Kim CS
Clin Genitourin Cancer; 2017 Apr; 15(2):e199-e204. PubMed ID: 27567188
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Treatments for Advanced Stage, Non-metastatic Upper Tract Urothelial Carcinoma: A Multicenter Study.
Kim M; Kim JK; Lee J; Kim YS; Lee JL; Kwak C; Jeong CW; Byun SS; Lee SC; Ohyama C; Arai Y; Ahn H
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):819-827. PubMed ID: 30922943
[TBL] [Abstract][Full Text] [Related]
7. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.
Thalmann GN; Markwalder R; Walter B; Studer UE
J Urol; 2002 Oct; 168(4 Pt 1):1381-5. PubMed ID: 12352398
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
9. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.
Liao RS; Gupta M; Schwen ZR; Patel HD; Kates M; Johnson MH; Hahn NM; McConkey D; Bivalacqua TJ; Pierorazio PM
J Urol; 2018 Jul; 200(1):68-73. PubMed ID: 29307680
[TBL] [Abstract][Full Text] [Related]
11. A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy.
Kitamura H; Igarashi M; Tanaka T; Shindo T; Masumori N; Tamakawa M; Kawaai Y; Tsukamoto T
Jpn J Clin Oncol; 2012 Dec; 42(12):1192-6. PubMed ID: 23077244
[TBL] [Abstract][Full Text] [Related]
12. RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.
Hagan MP; Winter KA; Kaufman DS; Wajsman Z; Zietman AL; Heney NM; Toonkel LM; Jones CU; Roberts JD; Shipley WU
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):665-72. PubMed ID: 14529770
[TBL] [Abstract][Full Text] [Related]
13. Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis.
Kobayashi H; Obata K
Cancer Chemother Pharmacol; 1994; 35 Suppl():S14-7. PubMed ID: 7994781
[TBL] [Abstract][Full Text] [Related]
14. Platinum-based chemotherapy for advanced transitional cell carcinoma of the upper urinary tract.
Lerner SE; Blute ML; Richardson RL; Zincke H
Mayo Clin Proc; 1996 Oct; 71(10):945-50. PubMed ID: 8820768
[TBL] [Abstract][Full Text] [Related]
15. Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy.
Lee KS; Kim KH; Yoon YE; Choi KH; Yang SC; Han WK
Korean J Urol; 2015 Jan; 56(1):41-7. PubMed ID: 25598935
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant methotrexate, vinblastine and cisplatin chemotherapy for invasive transitional cell carcinoma: Taiwan experience.
Wei CH; Hsieh RK; Chiou TJ; Chen KK; Chang LS; Chen PM
J Urol; 1996 Jan; 155(1):118-21. PubMed ID: 7490806
[TBL] [Abstract][Full Text] [Related]
17. Case records of the Massachusetts General Hospital. Case 30-2009. A 77-year-old man with recurrent transitional-cell carcinoma of the ureter.
Kaufman DS; McDougal WS; Harisinghani MG; Wu CL
N Engl J Med; 2009 Sep; 361(13):1292-9. PubMed ID: 19776411
[No Abstract] [Full Text] [Related]
18. Radiotherapy may improve overall survival of patients with T3/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse.
Chen B; Zeng ZC; Wang GM; Zhang L; Lin ZM; Sun LA; Zhu TY; Wu LL; Zhang JY; Ji Y
BMC Cancer; 2011 Jul; 11():297. PubMed ID: 21756352
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
Soga N; Arima K; Sugimura Y
Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
[TBL] [Abstract][Full Text] [Related]
20. Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experience.
Shirotake S; Kikuchi E; Tanaka N; Matsumoto K; Miyazaki Y; Kobayashi H; Ide H; Obata J; Hoshino K; Kaneko G; Hagiwara M; Kosaka T; Kanao K; Kodaira K; Hara S; Oyama M; Momma T; Miyajima A; Nakagawa K; Hasegawa S; Nakajima Y; Oya M
J Urol; 2015 Apr; 193(4):1122-8. PubMed ID: 25444957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]